The 8th RNAi-Based Therapeutics Summit is advancing RNAi candidates into clinically relevant therapies, focusing on bioavailability, translation, off-target effects, and manufacturing challenges.
Key Topics
Expanding the Therapeutic Potential of RNAi Drugs by Exhibiting the Next Generation of Therapies to Improve Drugging of Cancer Targets
Utilizing RNAi & Screening Approaches to Develop Specific Drugs for More Effective Treatment of Diseases
Achieving Stable & Efficacious siRNA Therapies by Optimizing Chemical Modifications Leading to Faster Approval
Leveraging Protein Conjugates for Extra-Hepatic Delivery to Broaden the Disease Landscape Currently Accessed
Delving into Novel Delivery Platforms & Strategies for Successful Delivery to the Liver & Beyond to Fast-Track More Effective Drugs through the Clinic
Illuminating Optimal Strategies for Faster Development of Novel RNAi Platforms to Enable Arrival to Patients Sooner
Navigating Critical Manufacturing Challenges to Improve Feasibility of RNAi Therapeutics & Allow Quicker Production
